HPV Vaccines
9
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Integration to Improve Adolescent Health and HPV Vaccination in Laos
Multiple Human Papillomavirus Infections in the Development of CIN
The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women
HPV Vaccine Integrated Service Implementation Research in Cameroon
HPV Vaccine Integrated Service Implementation Research in Ethiopia
Increasing HPV Vaccination in Community-Based Pediatric Practices
Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil
Giving Immunizations Through Vaccine Education
A School Health Center Intervention to Increase Adolescent Vaccination